These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21605928)

  • 1. Emerging options in the treatment of deep vein thrombosis and pulmonary embolism.
    Brenner B; Hoffman R
    Blood Rev; 2011 Sep; 25(5):215-21. PubMed ID: 21605928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations.
    Prandoni P
    Thromb Res; 2014 Aug; 134(2):227-33. PubMed ID: 24875390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing pulmonary embolism from presentation to extended treatment.
    Cohen AT; Dobromirski M; Gurwith MM
    Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging anticoagulants for the treatment of venous thromboembolism.
    Weitz JI
    Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update in the prevention and treatment of deep vein thrombosis and pulmonary embolism.
    Motsch J; Walther A; Bock M; Böttiger BW
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):52-8. PubMed ID: 16547433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New anticoagulants for treatment of venous thromboembolism.
    Franchini M; Mannucci PM
    Eur J Intern Med; 2012 Dec; 23(8):692-5. PubMed ID: 23095463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban.
    Sattari M; Lowenthal DT
    Am J Ther; 2011 Jul; 18(4):332-8. PubMed ID: 20535013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
    Daskalopoulos ME; Daskalopoulou SS; Liapis CD
    Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts for the prevention of venous thromboembolism.
    Bramlage P; Pittrow D; Kirch W
    Eur J Clin Invest; 2005 Mar; 35 Suppl 1():4-11. PubMed ID: 15701142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.
    Mavrakanas T; Bounameaux H
    Pharmacol Ther; 2011 Apr; 130(1):46-58. PubMed ID: 21185864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update in the treatment of venous thromboembolism.
    Garcia DA; Spyropoulos AC
    Semin Respir Crit Care Med; 2008 Feb; 29(1):40-6. PubMed ID: 18302085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
    Nutescu EA; Wittkowsky AK; Dobesh PP; Hawkins DW; Dager WE
    Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New treatments for venous thromboembolic disease].
    Combe S; Büller HR
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S16-9. PubMed ID: 22177764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis and coagulation: deep vein thrombosis and pulmonary embolism prophylaxis.
    Anaya DA; Nathens AB
    Surg Clin North Am; 2005 Dec; 85(6):1163-77, ix-x. PubMed ID: 16326200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.